197 related articles for article (PubMed ID: 30644322)
21. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
[TBL] [Abstract][Full Text] [Related]
22. Blockade of PLD1 potentiates the antitumor effects of bortezomib in multiple myeloma cells by inhibiting the mTOR/NF-κB signal pathway.
Wang Y; Dong F; Wan W; Zhang Z; Wang J; Wang H; Ke X
Hematology; 2020 Dec; 25(1):424-432. PubMed ID: 33191863
[TBL] [Abstract][Full Text] [Related]
23. Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury: Evidence for Smoothened-Mediated Activation of NF-κB/Epidermal Growth Factor Receptor/Akt in Hepatocytes that Counteract Fas-Induced Apoptosis.
Wang Y; Chen W; Han C; Zhang J; Song K; Kwon H; Dash S; Yao L; Wu T
Am J Pathol; 2018 Nov; 188(11):2605-2616. PubMed ID: 30366594
[TBL] [Abstract][Full Text] [Related]
24. DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma.
Uematsu A; Kido K; Manabe E; Takeda H; Takahashi H; Hayashi M; Imai Y; Sawasaki T
Biochem Biophys Res Commun; 2018 Jan; 495(3):2289-2295. PubMed ID: 29284118
[TBL] [Abstract][Full Text] [Related]
25. Activation of liver X receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma.
Agarwal JR; Wang Q; Tanno T; Rasheed Z; Merchant A; Ghosh N; Borrello I; Huff CA; Parhami F; Matsui W
Mol Cancer Ther; 2014 Jul; 13(7):1873-81. PubMed ID: 24807964
[TBL] [Abstract][Full Text] [Related]
26. The deubiquitinase UCHL5/UCH37 positively regulates Hedgehog signaling by deubiquitinating Smoothened.
Zhou Z; Yao X; Pang S; Chen P; Jiang W; Shan Z; Zhang Q
J Mol Cell Biol; 2018 Jun; 10(3):243-257. PubMed ID: 28992318
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
[TBL] [Abstract][Full Text] [Related]
28. Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
Du HF; Yu LJ; Meng YF; Lv HY; Meng J; Song XN; Zhang JQ
Leuk Lymphoma; 2013 Mar; 54(3):607-18. PubMed ID: 22889356
[TBL] [Abstract][Full Text] [Related]
29. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
[TBL] [Abstract][Full Text] [Related]
30. Role of Hedgehog-Gli1 signaling in the enhanced proliferation and differentiation of MG63 cells enabled by hierarchical micro-/nanotextured topography.
Lin Y; Huang Y; He J; Chen F; He Y; Zhang W
Int J Nanomedicine; 2017; 12():3267-3280. PubMed ID: 28458545
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
32. The Role of Smoothened in Cancer.
Jeng KS; Sheen IS; Leu CM; Tseng PH; Chang CF
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962123
[TBL] [Abstract][Full Text] [Related]
33. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.
Tozawa K; Sagawa M; Kizaki M
Int J Oncol; 2011 Nov; 39(5):1117-22. PubMed ID: 21850367
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway.
Xu Z; Huang C; Hao D
Oncol Rep; 2017 Feb; 37(2):1261-1269. PubMed ID: 27959416
[TBL] [Abstract][Full Text] [Related]
35. The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma.
Berenson JR; Ma HM; Vescio R
Semin Oncol; 2001 Dec; 28(6):626-33. PubMed ID: 11740821
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells.
Markovina S; Callander NS; O'Connor SL; Xu G; Shi Y; Leith CP; Kim K; Trivedi P; Kim J; Hematti P; Miyamoto S
Mol Cancer; 2010 Jul; 9():176. PubMed ID: 20604947
[TBL] [Abstract][Full Text] [Related]
37. ABT-199 inhibits Hedgehog pathway by acting as a competitive inhibitor of oxysterol, rather as a BH3 mimetic.
Wang J; Zhang Y; Huang WJ; Yang J; Tang WG; Huang TM; Tan WF
Acta Pharmacol Sin; 2021 Jun; 42(6):1005-1013. PubMed ID: 32855528
[TBL] [Abstract][Full Text] [Related]
38. Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib.
Rojas-Zambrano PM; Meyer-Herrera JE; Ruiz-Aparicio PF; Vernot JP
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175864
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Smoothened Trafficking and Hedgehog Signaling by the SUMO Pathway.
Ma G; Li S; Han Y; Li S; Yue T; Wang B; Jiang J
Dev Cell; 2016 Nov; 39(4):438-451. PubMed ID: 27746045
[TBL] [Abstract][Full Text] [Related]
40. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
